Outcomes of patients with decreased arterial oxyhaemoglobin saturation on pulmonary arterial hypertension drugs
S. Valentin (Nancy, France), A. Maurac (Nancy, France), O. Sitbon (Le Kremlin-Bicêtre, France), A. Beurnier (Le Kremlin-Bicêtre, France), E. Gomez (Nancy, France), A. Guillaumot (Nancy, France), L. Textoris (Nancy, France), R. Fay (Nancy, France), L. Savale (Le Kremlin-Bicêtre, France), X. Jaïs (Le Kremlin-Bicêtre, France), D. Montani (Le Kremlin-Bicêtre, France), F. Picard (Pessac, France), J. Mornex (Lyon, France), G. Prevot (Toulouse, France), F. Chabot (Nancy, France), M. Humbert (Le Kremlin-Bicêtre, France), A. Chaouat (Nancy, France)
Source: Virtual Congress 2021 – Therapy of pulmonary hypertension
Session: Therapy of pulmonary hypertension
Session type: E-poster
Number: 1923
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Valentin (Nancy, France), A. Maurac (Nancy, France), O. Sitbon (Le Kremlin-Bicêtre, France), A. Beurnier (Le Kremlin-Bicêtre, France), E. Gomez (Nancy, France), A. Guillaumot (Nancy, France), L. Textoris (Nancy, France), R. Fay (Nancy, France), L. Savale (Le Kremlin-Bicêtre, France), X. Jaïs (Le Kremlin-Bicêtre, France), D. Montani (Le Kremlin-Bicêtre, France), F. Picard (Pessac, France), J. Mornex (Lyon, France), G. Prevot (Toulouse, France), F. Chabot (Nancy, France), M. Humbert (Le Kremlin-Bicêtre, France), A. Chaouat (Nancy, France). Outcomes of patients with decreased arterial oxyhaemoglobin saturation on pulmonary arterial hypertension drugs. 1923
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: